Unlike other players in this value chain, pharma wholesalers margins are typically <5%. AB and others are being propped up as the culprit here while the other players are getting away w the real crime. They’re hardly even the “getaway driver”

ITT: ppl who have no understanding of the industry, see the word “opioid” and automatically assume AB is at fault because “big pharma”.

Also, from the article (AB’s statement):

“With the vast quantity of information that AmerisourceBergen shared directly with the DEA with regards to these five pharmacies, the DEA still did not feel the need to take swift action itself - in fact, AmerisourceBergen terminated relationships with four of them before DEA ever took any enforcement action while two of the five pharmacies maintain their DEA controlled substance registration to this day.

A Federal Judge recently held that AmerisourceBergen has maintained a compliance diversion control program in accordance with the law for decades. This sweeping decision addressed many of the same accusations that are made in this DOJ complaint while acknowledging the role of the DEA in controlled substance distribution with tools like manufacturing quotas - ultimately concluding that AmerisourceBergen had complied with the law.”

They are a wholesale distributor, not a manufacturer and not a pharmacy. They buy from manufacturers and sell to providers. They reported findings to DEA but they can’t be the ones making large scale decisions because if they’re wrong, patients are not getting what they need.

They’re not a manufacturer